Loading…
Charming Medical Limited is projected to rise to $39.33 by 2027, a +34% move from its current price of $29.36. MCTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $28.96 | $29.37 | $29.78 | +0.04% |
| Aug 3 | $28.80 | $29.38 | $29.96 | +0.08% |
| Aug 4 | $28.69 | $29.39 | $30.11 | +0.12% |
| Aug 5 | $28.59 | $29.40 | $30.23 | +0.15% |
| Aug 6 | $28.51 | $29.41 | $30.34 | +0.19% |
| Aug 7 | $28.44 | $29.42 | $30.44 | +0.23% |
| Aug 8 | $28.37 | $29.43 | $30.54 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $28.37 | $29.43 | $30.54 | +0.27% |
| Week 2 | $28.01 | $29.51 | $31.09 | +0.54% |
| Week 3 | $27.76 | $29.59 | $31.54 | +0.81% |
| Week 4 | $27.56 | $29.67 | $31.94 | +1.08% |
| Week 5 | $27.40 | $29.75 | $32.31 | +1.35% |
| Week 6 | $27.26 | $29.83 | $32.65 | +1.62% |
| Week 7 | $27.13 | $29.91 | $32.98 | +1.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Charming Medical Limited operates in the Healthcare sector, offering beauty, wellness, and postpartum services under the Beauty Lab brand in Hong Kong. Its services include womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, TCM-inspired prenatal massage, and Indonesian traditional abdominal binding. The company also provides TCM-inspired supplements and beauty products, and consultancy services for TCM-inspired therapy training and dietary therapy training to other beauty salons and wellness centers.
The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.
Charming Medical Limited (MCTA) is a healthcare company operating under the Beauty Lab brand in Hong Kong, offering beauty, wellness, and postpartum services. The current price is $29.36 with a market cap of $504.26M, and it ranks 2972 by market capitalization. The near-term price outlook is reflected in the 2026 forecast, which shows a min of $29.35, an average of $29.36, and a max of $39.54.
The 30-day trading range is $26.71 to $32.26, indicating a relatively tight near-term band around the current level.
A major floor 0.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major level 0.0% below — it may now act as a floor.
Key MCTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.35 | Buy | $29.35 | Buy |
| MA 10 | $29.35 | Buy | $29.35 | Buy |
| MA 20 | $29.35 | Buy | $29.35 | Buy |
| MA 50 | $29.35 | Buy | $29.34 | Buy |
| MA 100 | $29.35 | Buy | $28.82 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 78.51 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -66.67 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.00 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 50.00 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 0.00 | Neutral |
| Hull MA (9) | 29.35 | Buy |
| ADX (14) | 57.02 | Buy |
| ATR (14) | 0.00 | Info |
The 30-day technical picture shows neutral sentiment with RSI14 at 80 and the 50-day simple moving average at $29.35. Support and resistance are both pegged at $29.35, suggesting a very tight near-term level. The thirty-day range extends from $26.71 to $32.26, and the asset displays about 30% annualized volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.35 | $29.36 | $39.50 | 0% | Neutral | |
| $31.33 | $39.33 | $52.23 | +34% | Bullish | |
| $39.12 | $50.54 | $69.71 | +72% | Bullish | |
| $50.32 | $66.57 | $94.58 | +127% | Bullish | |
| $58.87 | $79.52 | $115.82 | +171% | Bullish | |
| $64.85 | $89.28 | $132.87 | +204% | Bullish | |
| $71.99 | $100.87 | $153.04 | +244% | Bullish | |
| $77.76 | $110.77 | $171.04 | +277% | Bullish | |
| $93.26 | $134.96 | $211.78 | +360% | Bullish | |
| $113.92 | $167.37 | $266.58 | +470% | Bullish | |
| $167.73 | $263.84 | $447.34 | +799% | Bullish | |
| $371.35 | $657.11 | $1,220.16 | +21.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $29.35 | $29.36 | $35.76 | +0.00% |
| September 2026 | $25.01 | $29.60 | $36.03 | +0.83% |
| October 2026 | $25.51 | $30.40 | $37.41 | +2.71% |
| November 2026 | $26.34 | $31.57 | $39.19 | +3.85% |
| December 2026 | $26.21 | $31.57 | $39.50 | -0.01% |
Click any year to see its month-by-month MCTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Charming Medical Limited's 2026 outlook centres on $29.36, within a $29.35 to $39.50 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MCTA could reach as high as $52.23, with a base case around $39.33 and support toward $31.33 — roughly +34% from $29.36. Buyers look set to stay in control over this stretch.
Expect MCTA to range from $39.12 to $69.71 through 2028. The $50.54 average target implies a +72% move from current prices. That is up +28% on the projected 2027 average. Momentum favours further upside here.
The MCTA price prediction for 2029 points to an average of $66.57 (low $50.32, high $94.58) — a potential gain of +127% on today's $29.36. Buyers look set to stay in control over this stretch.
In 2030, MCTA is projected to trade between $58.87 and $115.82, averaging $79.52 — a potential gain of +171% from today's $29.36. That is up +19% on the projected 2029 average. Momentum favours further upside here.
Charming Medical Limited's 2031 outlook centres on $89.28, within a $64.85 to $132.87 range. That is up +12% on the projected 2030 average. That marks a +204% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, MCTA could reach as high as $153.04, with a base case around $100.87 and support toward $71.99 — roughly +244% from $29.36. Momentum favours further upside here.
Expect MCTA to range from $77.76 to $171.04 through 2033. The $110.77 average target implies a +277% move from current prices. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The MCTA price prediction for 2034 points to an average of $134.96 (low $93.26, high $211.78) — a potential gain of +360% on today's $29.36. Momentum favours further upside here.
In 2035, MCTA is projected to trade between $113.92 and $266.58, averaging $167.37 — a potential gain of +470% from today's $29.36. That is up +24% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Charming Medical Limited's 2040 outlook centres on $263.84, within a $167.73 to $447.34 range. That is up +58% on the projected 2035 average. That marks a +799% change versus current levels. Momentum favours further upside here.
By 2050, MCTA could reach as high as $1,220.16, with a base case around $657.11 and support toward $371.35 — roughly +21.4x from $29.36. Buyers look set to stay in control over this stretch.
Investing $1,000 in MCTA today (≈ 34.065747 MCTA) could be worth
$22,384.95
+$21,384.95 (+2138%) by 2050 · US Dollar
Based on the average projected MCTA price of $657.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCTAwould be worth at today's price.
$1,000 invested in MCTA on Oct 21, 2025 (≈ 142.857143 MCTA) would be worth
$4,193.57
+$3,193.57 (+319.4%) today · 4.19× · US Dollar
Based on a MCTA entry price of $7 vs. today's $29.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.35 | $1,000 | +0.0% |
| 1 month ago | $29.35 | $1,000 | +0.0% |
| 3 months ago | $29.35 | $1,000 | +0.0% |
| 6 months ago | $29.35 | $1,000 | +0.0% |
| All time ago | $7 | $4,193.57 | +319.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCTA forecast.
Our base-case forecast reaches $59.00 around 2029.
Implied market cap at $59.00: $895.5M
The multi-year forecast points to a sustained upward trajectory, with 2026 at a flat start (min $29.35, avg $29.36, max $39.54, ROI 0, sentiment NEUTRAL) and a series of higher averages thereafter. By 2027 the avg is $39.94 with ROI 36.1% and bullish sentiment, rising to 2028 avg $51.62 (ROI 75.8%), 2029 avg $67.47 (ROI 129.8%), and 2030 avg $81.59 (ROI 177.9%). The path continues with 2031 avg $91.15 (ROI 210.5%), 2032 avg $102.56 (ROI 249.4%), 2033 avg $114.96 (ROI 291.6%), 2034 avg $139.39 (ROI 374.9%), and 2035 avg $171.83 (ROI 485.4%).
Beyond, 2040 is projected at avg $274.09 (ROI 833.7%) and 2050 at avg $680.75 (ROI 2219). These figures carry bullish sentiment from 2027 onward and are estimates, not guarantees, reflecting a potential substantial upside over the coming years while acknowledging inherent investment uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $81.59 with a minimum of $60.26 and a maximum of $119.16, and an estimated ROI of 177.9% with bullish sentiment.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROIs up to 2219% by 2050; 2026 starts neutral with an ROI of 0. These are estimates and not guarantees.
The maximum forecast by 2050 is $1,269.59, corresponding to an ROI of 2219%, which indicates the possibility of surpassing $1,000 in the long run.
The 30-day trading range is $26.71 to $32.26.
Current price is $29.36 and market cap is $504.26M.
Charming Medical Limited Community Discussion
0Share your Charming Medical Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.